Bastiaan Nuijen
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems 16
- Oncology top 5%
- Cancer Treatment and Pharmacology 25
- CAR-T cell therapy research 11
- Colorectal Cancer Treatments and Studies 10
- Biomaterials top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 17
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 9
-
- Safe Handling of Antineoplastic Drugs 13
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Jos H. BeijnenJan H.M. SchellensAlwin D. R. HuitemaGert StormMarjan BoumaJolanda M. van den HovenJohn B.A.G. HaanenJosbert M. Metselaar
- Journals
- International Journal of Pharmaceutics (16 papers)Journal of Pharmaceutical and Biomedical Analysis (8 papers)Annals of Oncology (5 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Bastiaan Nuijen
120 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 135
- Pharmaceutical Science 524
- Oncology 829
- Biomaterials 396
- Immunology 340
- Pharmacology 133
Countries citing papers authored by Bastiaan Nuijen
This map shows the geographic impact of Bastiaan Nuijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bastiaan Nuijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bastiaan Nuijen more than expected).
Fields of papers citing papers by Bastiaan Nuijen
This network shows the impact of papers produced by Bastiaan Nuijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bastiaan Nuijen. The network helps show where Bastiaan Nuijen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bastiaan Nuijen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 12 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 13 | |
| 9 | 2018 | 1 | |
| 10 | 2017 | 38 | |
| 11 | 2016 | 1 | |
| 12 | 2016 | 21 | |
| 13 | 2016 | 47 | |
| 14 | 2013 | 14 | |
| 15 | 2013 | 52 | |
| 16 | 2008 | 36 | |
| 17 | 2005 | 7 | |
| 18 | 2005 | 8 | |
| 19 | 2004 | 12 | |
| 20 | 2001 | 81 |
About Bastiaan Nuijen
Bastiaan Nuijen is a scholar working on Occupational Therapy, Pharmaceutical Science and Toxicology, having authored 122 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (25 papers), Immunotherapy and Immune Responses (17 papers), Drug Solubulity and Delivery Systems (16 papers), Safe Handling of Antineoplastic Drugs (13 papers), CAR-T cell therapy research (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer therapeutics and mechanisms (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). The work is most often cited by research in Pharmaceutical Science (524 citations), Oncology (829 citations) and Biomaterials (396 citations). Bastiaan Nuijen has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Jos H. Beijnen, Jan H.M. Schellens, Alwin D. R. Huitema, Gert Storm, Marjan Bouma, Jolanda M. van den Hoven, John B.A.G. Haanen, Josbert M. Metselaar, Joost H. van den Berg and Frederik E. Stuurman. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical and Biomedical Analysis, Annals of Oncology, Anti-Cancer Drugs and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.